Literature DB >> 22426982

Study of drug function based on similarity of pathway fingerprint.

Hao Ye1, Kailin Tang, Linlin Yang, Zhiwei Cao, Yixue Li.   

Abstract

Drugs sharing similar therapeutic function may not bind to the same group of targets. However, their targets may be involved in similar pathway profiles which are associated with certain pathological process. In this study, pathway fingerprint was introduced to indicate the profile of significant pathways being influenced by the targets of drugs. Then drug-drug network was further constructed based on significant similarity of pathway fingerprints. In this way, the functions of a drug may be hinted by the enriched therapeutic functions of its neighboring drugs. In the test of 911 FDA approved drugs with more than one known target, 471 drugs could be connected into networks. 760 significant associations of drug-therapeutic function were generated, among which around 60% of them were supported by scientific literatures or ATC codes of drug functional classification. Therefore, pathway fingerprints may be useful to further study on the potential function of known drugs, or the unknown function of new drugs.

Mesh:

Substances:

Year:  2012        PMID: 22426982      PMCID: PMC4875411          DOI: 10.1007/s13238-012-2011-z

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  39 in total

Review 1.  Network biology: understanding the cell's functional organization.

Authors:  Albert-László Barabási; Zoltán N Oltvai
Journal:  Nat Rev Genet       Date:  2004-02       Impact factor: 53.242

2.  Drug-target network.

Authors:  Muhammed A Yildirim; Kwang-Il Goh; Michael E Cusick; Albert-László Barabási; Marc Vidal
Journal:  Nat Biotechnol       Date:  2007-10       Impact factor: 54.908

3.  Schizophrenia patients at higher risk of diabetes, hypertension and hyperlipidemia: a population-based study.

Authors:  Chun-Hui Liao; Chen-Shu Chang; Wan-Ching Wei; Shih-Ni Chang; Chien-Chang Liao; Hsien-Yuan Lane; Fung-Chang Sung
Journal:  Schizophr Res       Date:  2011-01-08       Impact factor: 4.939

Review 4.  Osteopetrosis and osteoporosis: two sides of the same coin.

Authors:  F Lazner; M Gowen; D Pavasovic; I Kola
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

Review 5.  Trastuzumab in the treatment of non-small cell lung cancer.

Authors:  Christopher G Azzoli; Lee M Krug; Vincent A Miller; Mark G Kris; Robert Mass
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

6.  Predicting drug-target interaction networks based on functional groups and biological features.

Authors:  Zhisong He; Jian Zhang; Xiao-He Shi; Le-Le Hu; Xiangyin Kong; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

7.  Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks.

Authors:  Tao Huang; Xiao-He Shi; Ping Wang; Zhisong He; Kai-Yan Feng; Lele Hu; Xiangyin Kong; Yi-Xue Li; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

8.  The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.

Authors:  A P Anandarajah; E M Schwarz; S Totterman; J Monu; C Y Feng; T Shao; S A Haas-Smith; C T Ritchlin
Journal:  Ann Rheum Dis       Date:  2007-10-29       Impact factor: 19.103

9.  Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition.

Authors:  Lei Chen; Kai-Yan Feng; Yu-Dong Cai; Kuo-Chen Chou; Hai-Peng Li
Journal:  BMC Bioinformatics       Date:  2010-05-31       Impact factor: 3.169

10.  A global view of drug-therapy interactions.

Authors:  Jose C Nacher; Jean-Marc Schwartz
Journal:  BMC Pharmacol       Date:  2008-03-04
View more
  5 in total

1.  Construction of drug network based on side effects and its application for drug repositioning.

Authors:  Hao Ye; Qi Liu; Jia Wei
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

2.  Predicting inhibitory and activatory drug targets by chemically and genetically perturbed transcriptome signatures.

Authors:  Ryusuke Sawada; Michio Iwata; Yasuo Tabei; Haruka Yamato; Yoshihiro Yamanishi
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

3.  Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.

Authors:  Jieyi Di; Baotong Zheng; Qingfei Kong; Ying Jiang; Siyao Liu; Yang Yang; Xudong Han; Yuqi Sheng; Yunpeng Zhang; Liang Cheng; Junwei Han
Journal:  Mol Oncol       Date:  2019-08-21       Impact factor: 6.603

Review 4.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

5.  Pathway Analysis Revealed Potential Diverse Health Impacts of Flavonoids that Bind Estrogen Receptors.

Authors:  Hao Ye; Hui Wen Ng; Sugunadevi Sakkiah; Weigong Ge; Roger Perkins; Weida Tong; Huixiao Hong
Journal:  Int J Environ Res Public Health       Date:  2016-03-26       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.